Glibenclamide is an oral hypoglycaemic. It has a long duration of action and the relative risk of prolonged hypoglycaemia is therefore high. It is also relatively contraindicated in renal impairment as active metabolites accumulate.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page